Greenwich LifeSciences, Inc. - COM (GLSI)

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / COM
Total 13F shares
259,749
Share change
+147,904
Total reported value
$8,895,818
Price per share
$34.09
Number of holders
19
Value change
+$5,029,510
Number of buys
13
Number of sells
6

Institutional Holders of Greenwich LifeSciences, Inc. - COM (GLSI) as of Q1 2021

As of 31 Mar 2021, Greenwich LifeSciences, Inc. - COM (GLSI) was held by 19 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 259,749 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, HRT FINANCIAL LP, JACOBS LEVY EQUITY MANAGEMENT, INC, SkyOak Wealth, LLC, Creative Planning, CITADEL ADVISORS LLC, and MORGAN STANLEY. This page lists 19 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.